X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ASTRAZENECA PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ASTRAZENECA PHARMA MERCK LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 48.8 141.9 34.4% View Chart
P/BV x 6.4 21.5 29.8% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 MERCK LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ASTRAZENECA PHARMA
Mar-14
MERCK LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,285 82.5%   
Low Rs623634 98.3%   
Sales per share (Unadj.) Rs632.4189.6 333.6%  
Earnings per share (Unadj.) Rs45.7-0.2 -22,454.3%  
Cash flow per share (Unadj.) Rs62.33.8 1,620.9%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.868.6 566.5%  
Shares outstanding (eoy) m16.6025.00 66.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.35.1 26.3%   
Avg P/E ratio x18.4-4,712.7 -0.4%  
P/CF ratio (eoy) x13.5249.6 5.4%  
Price / Book Value ratio x2.214.0 15.5%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,96923,988 58.2%   
No. of employees `0001.61.6 101.5%   
Total wages/salary Rs m1,4871,605 92.7%   
Avg. sales/employee Rs Th6,631.93,040.2 218.1%   
Avg. wages/employee Rs Th939.21,029.2 91.2%   
Avg. net profit/employee Rs Th479.4-3.3 -14,683.6%   
INCOME DATA
Net Sales Rs m10,4984,740 221.5%  
Other income Rs m24292 263.2%   
Total revenues Rs m10,7414,832 222.3%   
Gross profit Rs m1,135-130 -874.7%  
Depreciation Rs m276101 272.2%   
Interest Rs m00-   
Profit before tax Rs m1,102-139 -793.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m3435 6,744.6%   
Profit after tax Rs m759-5 -14,909.6%  
Gross profit margin %10.8-2.7 -394.9%  
Effective tax rate %31.1-3.7 -850.0%   
Net profit margin %7.2-0.1 -6,731.3%  
BALANCE SHEET DATA
Current assets Rs m6,4102,726 235.1%   
Current liabilities Rs m8,8282,435 362.6%   
Net working cap to sales %-23.06.1 -374.8%  
Current ratio x0.71.1 64.8%  
Inventory Days Days5874 78.2%  
Debtors Days Days3841 94.2%  
Net fixed assets Rs m1,4061,035 135.8%   
Share capital Rs m16650 332.0%   
"Free" reserves Rs m6,286942 667.0%   
Net worth Rs m6,4551,716 376.1%   
Long term debt Rs m00-   
Total assets Rs m8,8284,156 212.4%  
Interest coverage xNMNM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.21.1 104.3%   
Return on assets %8.6-0.1 -7,018.8%  
Return on equity %11.8-0.3 -3,963.8%  
Return on capital %17.10-  
Exports to sales %8.35.7 145.3%   
Imports to sales %21.06.5 325.6%   
Exports (fob) Rs m869270 321.8%   
Imports (cif) Rs m2,209306 721.3%   
Fx inflow Rs m959375 256.0%   
Fx outflow Rs m2,612470 555.6%   
Net fx Rs m-1,653-96 1,730.2%   
CASH FLOW
From Operations Rs m1,070-8 -13,214.8%  
From Investments Rs m-750-146 514.6%  
From Financial Activity Rs m-150862 -17.4%  
Net Cashflow Rs m171709 24.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 0.3 6,066.7%  
FIIs % 1.0 15.7 6.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 9.1 319.8%  
Shareholders   28,591 12,856 222.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   WYETH LTD  IPCA LABS  NATCO PHARMA  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jun 22, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS